Pfizer Reorganizes To Handle Aging Consumers And PatentsPfizer, facing an aging population and shifting risks from the loss of patents, is reshaping the company into three businesses.
Pfizer Fined For Hiking Epilepsy Drug Price 2,600-Percent In UKBritish regulators fined U.S. drugmaker Pfizer and distributor Flynn Pharma a record $112.7 million Wednesday for increasing the cost of an epilepsy drug by as much as 2,600 percent.
Pfizer Says It's Blocking Use Of Drugs For Lethal InjectionsPharmaceutical company Pfizer has announced it is blocking use of its drugs in lethal injections, which means all federally-approved drugmakers whose medications could be used for executions have now put them off limits.
Allergan, Pfizer Call Off Proposed $160B MergerThe biggest U.S.-based drugmaker, Pfizer Inc., will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland — on paper — to reduce its tax bill.
Pfizer, Allergan In Deal Talks To Create Drug GiantPfizer and Botox maker Allergan are discussing a potential deal that could be the biggest of 2015, a year marked by a rapid-fire pace of megadeals, particularly in health care.
Texas AG Reaches Settlement On Alleged FraudAttorney General Greg Abbott's office announced the deal on Friday with Pfizer Inc. and Endo Pharmaceuticals. Each company will pay $18.1 million and attorney's fees.